Woohoo! #NEO -RT Trial activated ahead of schedule and ready to open! Thanks to all of the support!
Dr. Carl J Brown 🌎 CCTG NCI CTEP Clinical Research Josh Smith, MD, PhD, FACS Mark Whiteford Sharlene Gill, MD, MPH, MBA, FASCO Dr. Cathy Eng Karyn Goodman, MD, MS Jonathan Loree

A quick Xtorial:
1/10

So delighted to see our current and former Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center fellows come back for a visit!! Chris Cann, MD now at Fox Chase Cancer Center ✈️ in for the Colon Cancer Foundation #EAOCRC Summit!!! Vanderbilt Health Kathy Walsh, MD, MAEd #CancerResearch #crcsm #cancer

Toby Keith's death has raised a lot of questions about stomach cancer, including who it typically affects and how it's treated. Dr. Christopher Cann (Chris Cann, MD), of Fox Chase Cancer Center, shares important information on stomach cancer with Yahoo News: yhoo.it/491vxcn

Even if you’re young, colorectal cancer should be on your radar. Fox Chase's Dr. Chris Cann, MD shares with SELF that if you're dealing with digestive symptoms and they seem to drag on, or they just feel off, it’s “imperative” to speak to a doctor: self.com/story/how-to-p…

The Vanderbilt-Ingram Cancer Center team #dimsum pregamed to support our Division Chief Dr. jordan berlin for his 🤩👏🏻PHENOMENAL discussion yesterday @asco #GI24 with 2 former Vanderbilt University Medical Center fellows Chris Cann, MD Marc Roth. Kristen Ciombor Rajiv Agarwal MD Brian Grieb MD, PhD Dana Cardin, MD #Cancer

Our Phase III CO.32 NEO-RT trial is finalized and will open next month. Stoked to meet up with study champs and team at #GI24 . Please check your NCTN menu to activate when ready. ⁦CCTG⁩ ⁦Chris Cann, MD⁩ ⁦Noam VanderWalde⁩ ⁦⁦Dr. Carl J Brown 🌎⁩ ⁦

Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemo Naive Patients with Unresectable Colorectal Liver Metastases ⁦AnnalsSurgOncology⁩ ⁦SSAT⁩ ⁦⁩ ⁦Michael Lidsky, MD, FACS⁩ ⁦Lee M. Ocuin MD, FACS⁩ link.springer.com/article/10.124…

GREAT evening catching up with my @ecog NCI CTEP Clinical Research colleagues from Fox Chase Cancer Center Penn Medicine - Abramson Cancer Center Vanderbilt-Ingram Cancer Center and learning about new #CancerResearch concepts. We all have 1️⃣ 🎯 #curing #cancer . Kristen Ciombor Laura Goff Efrat Dotan MD Michael Gibson, MD PhD Vanderbilt University. Chris Cann, MD

Great work validating a regression score to better predict pathological response, William A Hall, MD . Excited to apply this in our #NEO -RT phase III trial of STAGE I #rectalcancer . Dr. Carl J Brown 🌎 NCI CTEP Clinical Research Chris Cann, MD Mark Whiteford Val Simianu

Fox Chase Cancer Center Welcomes Dr. Christopher G. Cann Chris Cann, MD Fox Chase Cancer Center #medtwitter ow.ly/2LRX50PCoar

'Current research suggests early-onset GI cancers may be influenced by changes in bacterial species of gut microbiome, early antibiotic exposure or environmental carcinogens.' says Chris Cann, MD in a Yahoo article on rising cancer rates in those under 50: yhoo.it/3KIp6Re

So fortunate to start my career as a GI oncologist at the institution where my medical training began Lewis Katz School of Medicine Fox Chase Cancer Center

I was honored 🙏🏻 to speak at Vanderbilt University Medical Center Grand Rounds yesterday on #earlyonset #colorectal #cancer . But MORE imp were these women: Mrs. Browning, a mom of 2 with stage 4 and also Ms. Tiffany Ewing, #MsBlackAlabama 2023 who lost her brother at 26 yo. THEIR stories need to…

Before embarking Fox Chase Cancer Center, our 🤩 fellow Chris Cann, MD VUMC Department of Medicine stopped to say 👋🏻 and remind me of my failed #Superbowl wager and gave me this gift + a photo of himself + Pat's King of Steaks!! 🙏🏻👏🏻Philadelphia Eagles Luv it! 😂 #cancer #mentorship Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center